628 related articles for article (PubMed ID: 34174723)
1. Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data.
Cari L; Fiore P; Naghavi Alhosseini M; Sava G; Nocentini G
J Autoimmun; 2021 Aug; 122():102685. PubMed ID: 34174723
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data.
Cari L; Alhosseini MN; Fiore P; Pierno S; Pacor S; Bergamo A; Sava G; Nocentini G
J Autoimmun; 2021 Dec; 125():102742. PubMed ID: 34710832
[TBL] [Abstract][Full Text] [Related]
3. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
Hippisley-Cox J; Patone M; Mei XW; Saatci D; Dixon S; Khunti K; Zaccardi F; Watkinson P; Shankar-Hari M; Doidge J; Harrison DA; Griffin SJ; Sheikh A; Coupland CAC
BMJ; 2021 Aug; 374():n1931. PubMed ID: 34446426
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
Greinacher A; Thiele T; Warkentin TE; Weisser K; Kyrle PA; Eichinger S
N Engl J Med; 2021 Jun; 384(22):2092-2101. PubMed ID: 33835769
[TBL] [Abstract][Full Text] [Related]
5. Age-Stratified Risk of Cerebral Venous Sinus Thrombosis After SARS-CoV-2 Vaccination.
Krzywicka K; van de Munckhof A; Sánchez van Kammen M; Heldner MR; Jood K; Lindgren E; Tatlisumak T; Putaala J; Kremer Hovinga JA; Middeldorp S; Levi MM; Cordonnier C; Arnold M; Zwinderman AH; Ferro JM; Coutinho JM; Aguiar de Sousa D
Neurology; 2022 Feb; 98(7):e759-e768. PubMed ID: 34921101
[TBL] [Abstract][Full Text] [Related]
6. Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort Study.
Hviid A; Hansen JV; Thiesson EM; Wohlfahrt J
Ann Intern Med; 2022 Apr; 175(4):541-546. PubMed ID: 35103482
[TBL] [Abstract][Full Text] [Related]
7. Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England.
Whiteley WN; Ip S; Cooper JA; Bolton T; Keene S; Walker V; Denholm R; Akbari A; Omigie E; Hollings S; Di Angelantonio E; Denaxas S; Wood A; Sterne JAC; Sudlow C;
PLoS Med; 2022 Feb; 19(2):e1003926. PubMed ID: 35192597
[TBL] [Abstract][Full Text] [Related]
8. Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US.
Li X; Burn E; Duarte-Salles T; Yin C; Reich C; Delmestri A; Verhamme K; Rijnbeek P; Suchard MA; Li K; Mosseveld M; John LH; Mayer MA; Ramirez-Anguita JM; Cohet C; Strauss V; Prieto-Alhambra D
BMJ; 2022 Oct; 379():e071594. PubMed ID: 36288813
[TBL] [Abstract][Full Text] [Related]
9. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.
Krzywicka K; Heldner MR; Sánchez van Kammen M; van Haaps T; Hiltunen S; Silvis SM; Levi M; Kremer Hovinga JA; Jood K; Lindgren E; Tatlisumak T; Putaala J; Aguiar de Sousa D; Middeldorp S; Arnold M; Coutinho JM; Ferro JM
Eur J Neurol; 2021 Nov; 28(11):3656-3662. PubMed ID: 34293217
[TBL] [Abstract][Full Text] [Related]
10. Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil.
Mouta Nunes de Oliveira P; Mendes-de-Almeida DP; Bertollo Gomes Porto V; Crespo Cordeiro C; Vitiello Teixeira G; Saraiva Pedro R; Roberto Gomes Takey P; Kegele Lignani L; Reis Xavier J; Cardoso Doria da Gama V; Amorim Filho L; Emoingt Furtado B; Santa Maria A; Dahrug Barros T; Neves Waite Freitas L; Dos Santos Pereira T; Lima Abreu D; Bernardes Ramos M; Gabe C; Arnold D; William Smith J; Nazy I; Lourdes de Sousa Maia M;
Vaccine; 2022 Aug; 40(33):4788-4795. PubMed ID: 35779962
[TBL] [Abstract][Full Text] [Related]
11. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
Kim AY; Woo W; Yon DK; Lee SW; Yang JW; Kim JH; Park S; Koyanagi A; Kim MS; Lee S; Shin JI; Smith L
Int J Infect Dis; 2022 Jun; 119():130-139. PubMed ID: 35339716
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Liu X; Shaw RH; Stuart ASV; Greenland M; Aley PK; Andrews NJ; Cameron JC; Charlton S; Clutterbuck EA; Collins AM; Dinesh T; England A; Faust SN; Ferreira DM; Finn A; Green CA; Hallis B; Heath PT; Hill H; Lambe T; Lazarus R; Libri V; Long F; Mujadidi YF; Plested EL; Provstgaard-Morys S; Ramasamy MN; Ramsay M; Read RC; Robinson H; Singh N; Turner DPJ; Turner PJ; Walker LL; White R; Nguyen-Van-Tam JS; Snape MD;
Lancet; 2021 Sep; 398(10303):856-869. PubMed ID: 34370971
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Stuart ASV; Shaw RH; Liu X; Greenland M; Aley PK; Andrews NJ; Cameron JC; Charlton S; Clutterbuck EA; Collins AM; Darton T; Dinesh T; Duncan CJA; England A; Faust SN; Ferreira DM; Finn A; Goodman AL; Green CA; Hallis B; Heath PT; Hill H; Horsington BM; Lambe T; Lazarus R; Libri V; Lillie PJ; Mujadidi YF; Payne R; Plested EL; Provstgaard-Morys S; Ramasamy MN; Ramsay M; Read RC; Robinson H; Screaton GR; Singh N; Turner DPJ; Turner PJ; Vichos I; White R; Nguyen-Van-Tam JS; Snape MD;
Lancet; 2022 Jan; 399(10319):36-49. PubMed ID: 34883053
[TBL] [Abstract][Full Text] [Related]
14. Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain.
Burn E; Roel E; Pistillo A; Fernández-Bertolín S; Aragón M; Raventós B; Reyes C; Verhamme K; Rijnbeek P; Li X; Strauss VY; Prieto-Alhambra D; Duarte-Salles T
Nat Commun; 2022 Nov; 13(1):7169. PubMed ID: 36418321
[TBL] [Abstract][Full Text] [Related]
15. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study.
Pottegård A; Lund LC; Karlstad Ø; Dahl J; Andersen M; Hallas J; Lidegaard Ø; Tapia G; Gulseth HL; Ruiz PL; Watle SV; Mikkelsen AP; Pedersen L; Sørensen HT; Thomsen RW; Hviid A
BMJ; 2021 May; 373():n1114. PubMed ID: 33952445
[TBL] [Abstract][Full Text] [Related]
16. Uncommon thrombotic complications after SARS-CoV-2 vaccination.
Musil D
Vnitr Lek; 2021; 67(5):297-302. PubMed ID: 35459396
[TBL] [Abstract][Full Text] [Related]
17. Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2.
Thiele T; Ulm L; Holtfreter S; Schönborn L; Kuhn SO; Scheer C; Warkentin TE; Bröker BM; Becker K; Aurich K; Selleng K; Hübner NO; Greinacher A
Blood; 2021 Jul; 138(4):299-303. PubMed ID: 33988688
[TBL] [Abstract][Full Text] [Related]
18. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.
Simpson CR; Shi T; Vasileiou E; Katikireddi SV; Kerr S; Moore E; McCowan C; Agrawal U; Shah SA; Ritchie LD; Murray J; Pan J; Bradley DT; Stock SJ; Wood R; Chuter A; Beggs J; Stagg HR; Joy M; Tsang RSM; de Lusignan S; Hobbs R; Lyons RA; Torabi F; Bedston S; O'Leary M; Akbari A; McMenamin J; Robertson C; Sheikh A
Nat Med; 2021 Jul; 27(7):1290-1297. PubMed ID: 34108714
[TBL] [Abstract][Full Text] [Related]
19. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response.
Franceschi AM; Petrover DR; McMahon TM; Libman RB; Giliberto L; Clouston SAP; Castillo M; Kirsch C
Clin Imaging; 2022 Oct; 90():63-70. PubMed ID: 35926315
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals who received COVID-19 adenoviral-vector-based vaccines.
Elberry MH; Abdelgawad HAH; Hamdallah A; Abdella WS; Ahmed AS; Ghaith HS; Negida A
J Thromb Thrombolysis; 2022 May; 53(4):798-823. PubMed ID: 35157188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
